Learning Objectives:

1.  To evaluate the efficacy and safety of terlipressin plus albumin in adults with hepatorenal syndrome.

2. To determine clinical significance of study results.

Session date: 
Friday, March 19, 2021 - 12:00pm to 1:00pm
Location: 
Zoom meeting
5700 S Maryland Ave
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Anand Narayanan, MD